lysine-methotrexate(80407-56-3)
- Name: lysine-methotrexate
- Synonyms:(S)-6-Amino-2-{4-[(2,4-diamino-pteridin-6-ylmethyl)-methyl-amino]-benzoylamino}-hexanoic acid;
- Molecular Formula:C21H27N9O3
- Molecular Weight:453.4976
- CAS Registry Number:80407-56-3
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.80407-56-3 lysine-methotrexate
Assay:99% Appearance:powder or liquid Package:according to customer requirements Storage:store in dry dark and ventilated place Transportation:By Sea/Air/Courier Application:It is an important raw material.
Min. Order:10Gram
Supplier:Zibo Hangyu Biotechnology Development Co., Ltd [
China (Mainland)] CAS No.80407-56-3 lysine-methotrexate
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.80407-56-3 lysine-methotrexate
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:lysine-methotrexate
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)] CAS No.80407-56-3 Methotrexate Impurity 2
Assay:95%+ or 98%+ Appearance:solid Package:10mg/25mg/50mg/100mg/1000mg/5000mg Storage:short-term storage normal temperature. long-term storage 2-8 鈩?nbsp;Application:for drug impurities, for drug standards,for drug research and development
Min. Order:0
Supplier:Hubei Moxin Biotechnology Co., Ltd [
China (Mainland)] CAS No.80407-56-3 Lysine-methotrexate
Assay:98% Appearance:Orange Solid Storage:Store at -20掳C Application:For research use only.
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 72076-44-9/Zinc, bis(2-(amino-kappaN)-4,5-dimethoxybenzenethiolato-kappaS)-, (T-4)-
- 157627-99-1/hexasodium 7-[[4-chloro-6-[4-[[4-chloro-6-[[5-hydroxy-7-sulfonato-6-[2-sulfonato-4-(4-sulfonatophenyl)azo-phenyl]azo-2-naphthyl]amino]-1,3,5-triazin-2-yl]amino]anilino]-1,3,5-triazin-2-yl]amino]-4-hydroxy-3-[2-sulfonato-4-(4-sulfonatophenyl)azo-phenyl]azo
- 85423-05-8/2-[(4-aminophenyl)methyl]-4-[[4-(ethylamino)phenyl]methyl]aniline
- 31407-74-6/O-Ethylisourea hydrochloride
- 53355-60-5/cyclic adenosine-5'-trimetaphosphate
- 5404-72-8/(5E)-5-[4-(diethylamino)benzylidene]-2-(morpholin-4-yl)-1,3-thiazol-4(5H)-one
- 113431-36-0/N-[2-(dimethylamino)ethyl]-4-phenylquinoline-8-carboxamide hydrochloride (1:1)
- 117411-09-3/phenylpropionyl-coenzyme A
- 67255-32-7/Ipasept
- 309720-04-5/(5,9-DIHYDRO-6,8-DIOXA-BENZOCYCLOHEPTEN-7-YL-METHYL)-P-TOLYL-AMINE
- 52643-54-6/3,6-dihydroxy-4,5-dimethylphthalaldehyde
- 12133-85-6/Tantalum, dodeca-m-chlorodichlorohexa-, octahedro
- 4025-16-5/methyl N-{[8-(3-thiophen-3-ylacryloyl)-2,8-diazaspiro[4.5]dec-2-yl]carbonyl}phenylalaninate
- 103144-63-4/5-Quinolinol,decahydro-2-methyl-1-(2-propenyl)-, benzoate (ester), (2a,4aa,5a,8ab)- (9CI)
- 130564-60-2/1-benzyl-4-[(2-nitrophenyl)carbonothioyl]piperazine hydrochloride
- 90342-40-8/Diphosphoric acid, reaction products with urea, diammonium salts
- 15603-76-6/Molybdenum,pentacarbonyl[(isocyano-kC)cyclohexane]-, (OC-6-21)- (9CI)
- 47066-92-2/3-[2-(1,3-dihydro-2H-isoindol-2-yl)ethyl]-1H-indole
- 168678-28-2/Peptide YY (Tilapianilotica) (9CI)
- 80407-56-3/lysine-methotrexate
- 174916-23-5/Amphiacrolide K
- 77787-47-4/CP 1110S
- 35325-49-6/ethyl 2-cyano-4-[1,3-dihydro-1,3,3-trimethyl-5-(5-methyl-2-benzoxazolyl)-2H-indole-2-ylidene]-2-butenoate
- 6376-89-2/1H,13H-Benz[4,5]isoquino[2,1-a]pyrido[3,4,5-gh]perimidine-1,3,13(2H)-trione(9CI)
- 19845-79-5/3,4,5,6,7,8,9,10,11,13-decahydro-14,16-dihydroxy-3-methyl-1,7-dioxo-
- 94113-47-0/3,3-dimethyl-1,5-dioxacycloundecane-6,11-dione
- 5336-67-4/decane-3,5-dione
- 55776-44-8/2-(4'-hydroxybenzylidene)cyclopentene-1,3-dione
- 61847-58-3/C.I. Basic Brown 14
- 93905-51-2/Fatty acids, castor-oil, caustic-oxidized, distn. residues, compdswith 4,5-dihydro-1H-imidazole-1-ethanamine 2 nortall-oil alkyl deriv.